Choose date and time: ×
In the last 2 hours
In the last 4 hours
'Consumed' - a Film Where Fiction Melds with GMO Facts Organic Consumers Association 20:53
In the last 8 hours
Earlier today
In the last 7 days
Texas is growing into a bioscience power Houston Chronicle, Texas 21:03 21-Oct-16
Sun Pharma completes divestment of 7 brands to RPG The Times of India 20:01 21-Oct-16
Supreme Court backs NPPA on capping drug prices The Times of India 19:51 21-Oct-16
Atomic-scale MRI Holds Promise for New Drug Discovery Drug Discovery & Development 19:24 21-Oct-16
Gilead Sciences: Still Needs M&A Barron's Online 19:20 21-Oct-16
RPG Life Sciences reports 22% growth in sales The Times of India 19:10 21-Oct-16
Biosimilars boost Biocon net to ₹147 cr in September quarter The Hindu Business Line 18:23 21-Oct-16
Gilead Sciences: These Things Take Time Barron's Online 17:39 21-Oct-16
Biotech Snapshot: AveXis Seeking Alpha 15:39 21-Oct-16
If This Fails, Biotech Is In Trouble 15:36 21-Oct-16
ArQule Is Undervalued Going Into Catalyst Events Seeking Alpha 15:08 21-Oct-16
Stocks in focus: RIL, Biocon The Hindu Business Line 08:48 21-Oct-16
Gilead Sciences to advance NASH treatment into phase III trials Proactive Investors (UK) 08:28 21-Oct-16
Biocon Q2 FY17 Revenue up 21% at Rs 992 crore India Info Line 06:39 21-Oct-16
Biocon shares hit fresh 52-week high post Q2 results The Times of India 06:33 21-Oct-16
Biocon hits record high on strong Q2 earnings The Business Standard 06:17 21-Oct-16
Vaxil collaborates with Israel’s Hadassah Medical Center Proactive Investors (USA & Canada) 21:33 20-Oct-16
Biocon profit at Rs 147 cr, revenue up 21% The Business Standard 21:22 20-Oct-16
Diagnosing The Health Care Sell-Off Seeking Alpha 20:55 20-Oct-16
Biomarin Comes Up Short With Vosoritide Seeking Alpha 20:35 20-Oct-16
Abbvie Exit Forces Ablynx Into Plan B Seeking Alpha 19:34 20-Oct-16
Stop “Gene Spills” Before They Happen MIT Technology Review 19:20 20-Oct-16
CRISPR's Bad IPO Timing Is Costly Bloomberg 18:32 20-Oct-16
Biocon reports Q2 profit of Rs 147 crore The Times of India 18:30 20-Oct-16
Kite Takes On The World Seeking Alpha 18:24 20-Oct-16
Cempra: Solithera Could Become A Blockbuster Seeking Alpha 17:30 20-Oct-16
Biocon posts 52% rise in net profit in Q2FY17 The Economic Times 17:29 20-Oct-16
Biocon profit up 52% to Rs.147 crore in Q2 17:09 20-Oct-16
Gilead Sciences: ‘Far From Compelling’ Barron's Online 16:10 20-Oct-16
Biotechnology: The trials of Juno The Economist 15:58 20-Oct-16
Thursday's ETF Movers: XBI, XME Forbes 15:49 20-Oct-16
Biotech Stocks: Do Earnings Even Matter Anymore? Barron's Online 15:10 20-Oct-16
AbbVie Knocks Back Ablynx's Vobarilizumab In RA 15:03 20-Oct-16

No account? Sign up!

  • Bookmark your favourite topics and create your very own NewsNow page.
  • Save publication preferences and your reading history for quick reference.
  • Take this with you whenever and wherever you sign in!

Publication filters

Headline Density

  • This site uses cookies. To see how, read our Privacy and Cookie Notice. If you disagree with our use of cookies, please navigate away.
Sorry, no headlines or news topics were found. Please try different keywords.